The feasibility of a single-blinded fast-track pragmatic randomised controlled trial of a complex intervention for breathlessness in advanced disease

Morag C Farquhar, Irene J Higginson, Petrea Fagan, Sara Booth, Morag C Farquhar, Irene J Higginson, Petrea Fagan, Sara Booth

Abstract

Background: The Breathlessness Intervention Service is a novel service for patients with intractable breathlessness regardless of aetiology. It is being evaluated using the Medical Research Council's framework for the evaluation of complex interventions. This paper describes the feasibility results of Phase II: a single-blinded fast-track pragmatic randomised controlled trial.

Methods: A single-blinded fast-track pragmatic randomised controlled trial was conducted for patients with chronic obstructive pulmonary disease referred to the service. Patients were randomised to either receive the intervention immediately for an eight-week period, or receive the intervention after an eight-week period on a waiting list during which time they received standard care. Outcomes examined included: response rates to the trial; response rates to the individual questionnaires and items; comments relating to the trial functioning made during interviews with patients, carers, referrers and service providers; and, researcher fieldwork notes.

Results: 16 of the 20 eligible patients agreed to participate in a recruitment visit (16/20); 14 respondents went on to complete a recruitment visit/baseline interview. The majority of those who completed a recruitment visit/baseline interview completed the RCT protocol (13/14); 12 of their carers were recruited and completed the protocol. An unblinding rate of 6/25 respondents (patients and carers) was identified. Missing data were minimal and only one patient was lost to follow up. The fast-track trial methodology proved feasible and acceptable. Two of the baseline/outcome measures proved unsuitable: the WHO performance scale and the Schedule for the Evaluation of Individual Quality of Life-Direct Weighting (SEIQoL-DW).

Conclusion: This study adds to the evidence that fast-track randomised controlled trials are feasible and acceptable in evaluations of palliative care interventions for patients with non-malignant conditions. Reasonable response rates and low attrition rates were achieved. Further, with adequate preparation of the research and randomisation teams, clinicians, and responders, and effective liaison with the clinicians, single-blinding proved possible. Methods were identified to reduce unblinding through careful attention to the type of data collected at unblinded measurement points; the content of interviews should be carefully considered when designing blinded-trial protocols.

Trial registration: Clinical Trials.gov NCT00711438.

Figures

Figure 1
Figure 1
Flow chart depicting the follow up measurement points
Figure 2
Figure 2
CONSORT flow chart summarising the numbers for study enrolment, randomisation, allocation, follow up and analysis

References

    1. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage. 2006;31:58–69. doi: 10.1016/j.jpainsymman.2005.06.007.
    1. Corner J, Plant H, A'Hern R, Bailey C. Non-pharmacological intervention for breathlessness in lung cancer. Palliat Med. 1996;10:299–305. doi: 10.1177/026921639601000405.
    1. Bredin M, Corner J, Krishnasamy M, Plant H, Bailey C, A'Hern R. Multicentre randomised control trial of nursing intervention for breathlessness in patients with lung cancer. BMJ. 1999;318:901–904.
    1. Hately J, Laurence V, Scott A, Baker R, Thomas P. Breathlessness clinics within specialist palliative care settings can improve the quality of life and functional capacity of patients with lung cancer. Palliat Med. 2003;17:410–417. doi: 10.1191/0269216303pm752oa.
    1. Connors S, Graham S, Peel T. An evaluation of a physiotherapy led non-pharmacological breathlessness programme for patients with intrathoracic malignancy. Palliat Med. 2007;21:285–287. doi: 10.1177/0269216307079172.
    1. MRC . A framework for development and evaluation of RCTs for complex interventions to improve health. London: MRC; 2000.
    1. Booth S. Improving research methodology in breathlessness: a meeting convened by the MRC Clinical Trials Unit and the Cicely Saunders Foundation. Palliat Med. 2006;20:219–220. doi: 10.1191/0269216306pm1132xx.
    1. Grande GE, Todd CJ. Why are trials in palliative care so difficult? Palliat Med. 2000;14:69–74. doi: 10.1191/026921600677940614.
    1. Higginson IJ, Vivat B, Silber E, Saleem T, Burman R, Hart S, Edmonds P. Study protocol: delayed intervention randomised controlled trial within the Medical Research Council (MRC) Framework to assess the effectiveness of a new palliative care service. BMC Palliat Care. 2006;2:7. doi: 10.1186/1472-684X-5-7.
    1. Higginson IJ, Hart S, Burman R, Silber E, Saleem T, Edmonds P. Randomised controlled trial of a new palliative care service: compliance, recruitment and completeness of follow-up. BMC Palliat Care. 2008;7:7. doi: 10.1186/1472-684X-7-7.
    1. McWhinney IR, Bass MJ, Donner D. Evaluation of a palliative care service: problems and pitfalls. BMJ. 1994;309:1340–1342.
    1. Hart T, Fann JR, Novack TA. The dilemma of the control condition in experience-based cognitive and behavioural treatment research. Neuropsychol Rehabil. 2008;18:1–21. doi: 10.1080/09602010601082359.
    1. Booth S, Silvester S, Todd C. Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers. J Palliat Support Care. 2003;1:337–344.
    1. Booth S, Farquhar M, Gysels M, Bausewein C, Higginson IJ. The impact of a breathlessness intervention service (BIS) on the lives of patients with intractable dyspnoea: a qualitative Phase I study. J Palliat Support Care. 2006;4:287–293.
    1. Holloway E, Ram FSF. Breathing exercises for asthma. Cochrane Database Syst Rev. 2004:CD001277.
    1. World Health Organisation . WHO handbook for reporting results of cancer treatment. Geneva: WHO; WHO offset publication No. 48; 1979.
    1. Hickey AM, Bury G, O'Boyle CA, Bradley F, O'Kelly FD, Shannon W. A new short form individual quality of life measure (SEIQoL-DW): application in a cohort of individuals with HIV/AIDS. BMJ. 1996;313:29–33.
    1. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42:773–778. doi: 10.1136/thx.42.10.773.
    1. Burdon JGW, Juniper EF, Killian FE, Hargreave FE, Campbell EJM. The perception of breathlessness in asthma. Am Rev Respir Dis. 1982;126:825–828.
    1. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist. 1980;20:649–655.
    1. Lawton MP, Kleban MH, Moss M, Rovine M, Glicksman A. Measuring caregiving appraisal. J Gerontol. 1989;44:61–71.
    1. Charles M, Reymond L, Israel F. Relief of incident dyspnea in palliative cancer patients: a pilot randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline. J Pain Symptom Manage. 2008;36:29–38. doi: 10.1016/j.jpainsymman.2007.08.016.
    1. Hopkinson JB, Wright DNM, Corner JL. Seeking new methodology for palliative care research: challenging assumptions about studying people who are approaching the end of life. Palliat Med. 2005;19:523–537. doi: 10.1191/0269216305pm1049oa.
    1. Ewing G, Rogers M, Barclay S, McCabe J, Martin A, Todd C. Recruiting patients into a primary care based study of palliative care: why is it so difficult? Palliat Med. 2004;18:452–459. doi: 10.1191/0269216304pm905oa.
    1. Kendall M, Harris F, Boyd K, Sheikh A, Murray SA, Brown D, Mallinson I, Kearney N, Worth A. Key challenges and ways forward in researching the "good death": qualitative in-depth interview and focus group study. BMJ. 2007;334:521–526. doi: 10.1136/bmj.39097.582639.55.
    1. White C, Gilshenan K, Hardy J. A survey of the views of palliative care healthcare professionals towards referring cancer patients to participate in randomized controlled trials in palliative care. Support Care Cancer. 2008;16:1397–1405. doi: 10.1007/s00520-008-0441-1.
    1. White CD, Hardy JR, Gilshenan KS, Charles MA, Pinkerton CR. Randomised controlled trials of palliative care – a survey of the views of advanced cancer patients and their relatives. European Journal of Cancer Care. 2008;44:1820–1828.
    1. Oliver SM. Living with failing lungs: the doctor-patient relationship. Fam Pract. 2001;18:430–439. doi: 10.1093/fampra/18.4.430.
    1. Elkington H, White P, Addington-Hall J, Higgs R, Pettinari C. The last year of life of COPD: a qualitative study of symptoms and services. Respir Med. 2004;98:439–445. doi: 10.1016/j.rmed.2003.11.006.
    1. Elkington H, White P, Addington-Hall J, Higgs R, Edmonds P. The healthcare needs of chronic obstructive pulmonary disease patients in the last year of life. Palliat Med. 2005;19:485–491. doi: 10.1191/0269216305pm1056oa.
    1. Skilbeck J, Mott S, Page H, Smith D, Hjelmeland-Ahmedzai S, Clark D. Palliative care assessment in chronic obstructive airways disease – a needs assessment. Palliat Med. 1998;12:245–254. doi: 10.1191/026921698677124622.
    1. Exley C, Field D, Jones L, Stokes T. Palliative care in the community for cancer and end-stage cardiorespiratory disease: the views of patients, lay-carers and health care professionals. Palliat Med. 2005;19:76–83. doi: 10.1191/0269216305pm973oa.
    1. Yohannes AM. Palliative care provision for patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2007;5:17. doi: 10.1186/1477-7525-5-17.
    1. Booth S. MD thesis. London; University of London; 2009. Improving the palliative care of patients with intractable breathlessness.
    1. Abernethy A, Shelby-James T, Fazekas B, Woods D, Currow D. The Australia-modified Karnofsky Performance Status (AKPS) Scale: a revised scale for contemporary palliative care clinical practice. BMC Palliat Care. 2005;4:7. doi: 10.1186/1472-684X-4-7.
    1. Karnofsky D, Abelmann W, Craver L, Burchenal J. The use of nitrogen mustard in the palliative treatment of cancer. Cancer. 1948;1:634–656. doi: 10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>;2-L.
    1. Nikoletti S, Porock D, Kristjanson LJ, Medigovich K, Pedler P, Smith M. Performance status assessment in home hospice patients using a modified form of the Karnofsky Performance Status scale. J Palliat Med. 2000;3:301–311. doi: 10.1089/jpm.2000.3.301.
    1. Farquhar M, Higginson IJ, Booth S. Repeated measurement of quality of life in palliative care research: the experience of using the SEIQoL-DW in a pilot phase II RCT of a complex intervention for breathlessness [abstract] Palliat Med. 2008;22:596.
    1. The EuroQol Group EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208. doi: 10.1016/0168-8510(90)90421-9.
    1. Guthrie SJ, Hill KM, Muers MF. Living with COPD. A qualitative exploration of the experience of patients in Leeds. Respir Med. 2001;95:196–204. doi: 10.1053/rmed.2000.1021.
    1. Von Gunten CF. Interventions to manage symptoms at the end of life. J Palliat Med. 2005;8:s-88. doi: 10.1089/jpm.2005.8.s-88.
    1. Bausewein C, Malik F, Booth S, Higginson IJ. Recent developments in managing breathlessness: international researchers' meeting on Breathlessness in London, November 2006. Progress in Palliative Care. 2007;15:279–284. doi: 10.1179/096992607X236434.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa